Armata Pharmaceuticals (ARMP) Profit After Tax: 2013-2018
Historic Profit After Tax for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.
- Armata Pharmaceuticals' Profit After Tax rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 23.75%. This contributed to the annual value of -$18.9 million for FY2024, which is 72.60% up from last year.
- Latest data reveals that Armata Pharmaceuticals reported Profit After Tax of -$1.1 million as of Q4 2018, which was up 60.27% from -$2.8 million recorded in Q3 2018.
- Armata Pharmaceuticals' Profit After Tax's 5-year high stood at $21.2 million during Q3 2014, with a 5-year trough of -$14.5 million in Q1 2015.
- For the 3-year period, Armata Pharmaceuticals' Profit After Tax averaged around -$4.1 million, with its median value being -$3.1 million (2016).
- The largest annual percentage gain for Armata Pharmaceuticals' Profit After Tax in the last 5 years was 194.74% (2014), contrasted with its biggest fall of 587.36% (2014).
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Profit After Tax stood at -$664,000 in 2014, then plummeted by 235.99% to -$2.2 million in 2015, then tumbled by 325.82% to -$9.5 million in 2016, then surged by 75.24% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
- Its Profit After Tax was -$1.1 million in Q4 2018, compared to -$2.8 million in Q3 2018 and -$9.7 million in Q2 2018.